Laron Syndrome: Siblings with Extreme Short Stature and Very High Growth Hormone

Sharmin- Jahan^1, , Hasanat MA¹, Nusrat- Sultana¹, Shadequl-Islam AHM¹, Satyajit- Mallick¹, Saifur-Rahman M¹ and Fariduddin M¹

¹Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh

Cite this paper

Sharmin- Jahan, Hasanat MA, Nusrat- Sultana, Shadequl-Islam AHM, Satyajit- Mallick, Saifur-Rahman M and Fariduddin M. Laron Syndrome: Siblings with Extreme Short Stature and Very High Growth Hormone. American Journal of Medical Case Reports. 2016; 4(6):198-203. doi: 10.12691/AJMCR-4-6-4

Abstract

Primary growth hormone resistance or growth hormone insensitivity syndrome (GHIS), also known as Laron syndrome, is a hereditary disease caused by deletions or different types of mutations in the growth hormone receptor gene or by post-receptor defects. This disorder is characterized by a clinical appearance attributable to severe growth hormone deficiency with high levels of circulating growth hormone in contrast to low serum insulin-like growth factor-1 (IGF-1) and low serum insulin-like growth factor binding protein (IGFBP-3)values. It is an autosomal recessive disorder and to date, more than 70 unique growth hormone receptor (GHR) mutations have been identified in more than 250 GHIS patients. We report the case of an 8-year-old boy and his 12-year-old sister born to first cousin parent that presented with severe short stature who had the classic feature of GH deficiency. Investigations revealed high plasma GH levels in both the cases. Subsequently, IGF-1 and IGFBP-3 assay were done and the levels were found to be very low. These reports along with elevated GH level in the context of typical picture of GH deficiency confirmed the diagnosis of GHIS. Genetic testing could not be done because of unavailability in our context. Regrettably specific therapy in the form of recombinant IGF-1 could not be offered as it is not commercially available in our country.

Keywords

Laron syndrome, growth hormone insensitivity, short stature, IGF-1, IGFBP-3

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Louise A. Metherell, Helen L. Storr, Martin O. Savage. Genetic defects of the human somatotropic axis. In: Wass JAH, Stewart PM (eds). Oxford textbook of Endocrinology and Diabetes. 2nd edn. Oxford Univ. Press, 2011; p-1062.
[2]	Laron Z. Growth hormone insensitivity (Laron syndrome). Reviews in Endocrine and Metabolic Disorders 2002; 3: 347-55.
[3]	Chakrabothy PP. Basu AK. Mandal SK.Dipanjan B. Laron’s syndrome in two siblings. Indian Journal of Pediatrics 2007; 74: 870-1.
[4]	Oana R Cotta, Libero Santarpia, Lorenzo Curtò, Gianluca Aimaretti, Ginevra Corneli, Francesco Trimarch and Salvatore Cannavò. Primary growth hormone insensitivity (Laron syndrome) and acquired hypothyroidism: a case report. Journal of Medical Case Reports 2011; 5:301.
[5]	Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone: a new inborn error of metabolism? Isr J Med Sci 1966; 2:152-155.
[6]	Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Francke U. Growth hormone receptor deficiency in Ecuador. J Clin Endocrinol Metab 1999; 84:4436-4443.
[7]	Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J Clin Endocrinol Metab 2004; 89:1031-1044.
[8]	Savage MO, Attie KM, David A, Metherell LA, Clark AJ, Camacho-Hübner C.Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders. Nat Clin Pract Endocrinol Metab 2006; 2:395-407.
[9]	Laron Z, Lilos P, Klinger B. Growth curves for Laron syndrome. Arch Dis Child 1993; 68:768-770.
[10]	Eshet R, Laron Z, Pertzelan A, Dintzman M. Defect of human growth hormone in the liver of two patients with Laron type dwarfism. Isr J Med Sci 1984; 20:8-12.
[11]	Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE. GH Insensitivity Syndrome Collaborative Group: Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 2007; 3:902-910.
[12]	Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 2001; 229:141-162.
[13]	Laron Z. The GH-IGF1 axis and longevity: the paradigm of IGF1 deficiency. Hormones 2008; 7:24-27.